Overview
Taku Yamashita practices practicing medicine in Kanagawa, Japan.
Mr. Yamashita is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Hearing Loss, Mediastinitis, Laryngectomy, and Endoscopy.
He is actively involved in clinical research, co-authoring 130 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Taku Yamashita
Is Taku Yamashita a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Taku Yamashita is classified as an Distinguished expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Taku Yamashita participate in research or clinical trials?
Yes. Taku Yamashita has published 130 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Taku Yamashita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Head and Neck Squamous Cell Carcinoma (HNSCC)Mr. Yamashita isDistinguished. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- Advanced
- Feingold SyndromeMr. Yamashita isAdvanced. Learn about Feingold Syndrome.
- Hearing LossMr. Yamashita isAdvanced. Learn about Hearing Loss.
- LaryngectomyMr. Yamashita isAdvanced. Learn about Laryngectomy.
- MediastinitisMr. Yamashita isAdvanced. Learn about Mediastinitis.
- Experienced
- Anaplastic Thyroid CancerMr. Yamashita isExperienced. Learn about Anaplastic Thyroid Cancer.
- Bell's PalsyMr. Yamashita isExperienced. Learn about Bell's Palsy.
- Cerebral Cavernous MalformationMr. Yamashita isExperienced. Learn about Cerebral Cavernous Malformation.
- CholesteatomaMr. Yamashita isExperienced. Learn about Cholesteatoma.
- EndoscopyMr. Yamashita isExperienced. Learn about Endoscopy.
- Esophageal CancerMr. Yamashita isExperienced. Learn about Esophageal Cancer.
- Facial ParalysisMr. Yamashita isExperienced. Learn about Facial Paralysis.
- Familial OtosclerosisMr. Yamashita isExperienced. Learn about Familial Otosclerosis.
- Ganglion CystMr. Yamashita isExperienced. Learn about Ganglion Cyst.
- Infant Hearing LossMr. Yamashita isExperienced. Learn about Infant Hearing Loss.
- Laryngeal CancerMr. Yamashita isExperienced. Learn about Laryngeal Cancer.
- Meniere DiseaseMr. Yamashita isExperienced. Learn about Meniere Disease.
- Muscle AtrophyMr. Yamashita isExperienced. Learn about Muscle Atrophy.
- NecrosisMr. Yamashita isExperienced. Learn about Necrosis.
- Neuroendocrine TumorMr. Yamashita isExperienced. Learn about Neuroendocrine Tumor.
- OtosclerosisMr. Yamashita isExperienced. Learn about Otosclerosis.
- PerichondritisMr. Yamashita isExperienced. Learn about Perichondritis.
- Renal OncocytomaMr. Yamashita isExperienced. Learn about Renal Oncocytoma.
- Salivary Gland TumorsMr. Yamashita isExperienced. Learn about Salivary Gland Tumors.
- SchwannomaMr. Yamashita isExperienced. Learn about Schwannoma.
- Throat CancerMr. Yamashita isExperienced. Learn about Throat Cancer.
- Tongue CancerMr. Yamashita isExperienced. Learn about Tongue Cancer.